Tag Archives: NASDAQ:CBRX

Healthcare Marks Solo Flight to Green Land; Bristol Myers (BMY) Misses Forecasts while Eli Lilly’s (LLY) Net Up in Third Quarter – BMY, LLY, PFE, KIPS, CBRX, UTHR

Posted on October 25, 2012 by Geoff Noir

Healthcare was the only sector which finished in positive territory on Wednesday but surged slightly up, +0.01%. If we look at the key movers of the sector so Kips Bay Medical, Inc (NASDAQ:KIPS) and Columbia Laboratories Inc (NASDAQ:CBRX) were major …

Posted in Healthcare, Latest Headlines | Tagged BMY, Bristol-Myers Squibb, CBRX, Columbia Laboratories, Eli Lilly, KIPS, Kips Bay Medical, LLY, NASDAQ:CBRX, NASDAQ:KIPS, NASDAQ:UTHR, NYSE:BMY, NYSE:LLY, NYSE:PFE, PFE, Pfizer, United Therapeutics, UTHR | Comments Off

PetMed Express (NASDAQ:PETS) Disappoints Investors with Results- PETS, VRX, ELN, ALKS, HSP, CBRX, KV.A

Posted on May 8, 2012 by Geoff Noir

Shares of pet pharmacy firm Petmed Express Inc (NASDAQ:PETS) plummeted 19% on Monday following the firm posted in its Q4 earnings how much and advertising blitz had reduced into profit.

While revenue increased 10%, gains were wiped out by spending …

Posted in Healthcare, Latest Headlines | Tagged Alkermes, ALKS, CBRX, Columbia, Elan, ELN, Hospira, HSP, K-V Pharmaceutical, KV-A, NASDAQ:ALKS, NASDAQ:CBRX, NASDAQ:PETS, NYSE:ELN, NYSE:HSP, NYSE:KV-A, NYSE:VRX, PetMed Express, pets, Valeant Pharmaceuticals, VRX | Comments Off

Monday’s sinking stocks and the reasons why (CBRX, RIMM, TWIN)

Posted on January 23, 2012 by Martin Timble

In this report: Columbia Laboratories (NASDAQ:CBRX), Research in Motion (NASDAQ:RIMM) and Twin Disc (NASDAQ:TWIN).

Columbia Laboratories (NASDAQ:CBRX) has tanked by more than 58 percent today after an advisory panel of the Food and Drug Administration voted against the approval of …

Posted in Latest Headlines, Reports | Tagged CBRX, CEO, Columbia Laboratories, Deutsche Bank, earnings, FDA, financials, firm, Food and Drug Administration, Jim Balsillie, Mike Lazardis, NASDAQ, NASDAQ:CBRX, NASDAQ:RIMM, NASDAQ:TWIN, oil and gas, progesterone, quarter, rating, report, Research in Motion, revenue, RIMM, TWIN, Twin Disc, upgrade | Comments Off

Soaring stocks and the reasons why (LLTC, UEPS, CBRX)

Posted on January 18, 2012 by Cameron White

In this report: Columbia Laboratories (NASDAQ:CBRX), Net 1 UEPS Technologies (NASDAQ:UEPS) and Linear Technology Corp. (NASDAQ:LLTC).

Columbia Laboratories (NASDAQ:CBRX) shares are rebounding today after seeing a more than 56 percent drop yesterday. The selloff came after reviewers from the Food …

Posted in Latest Headlines, Reports | Tagged Analysts, cash paymaster services, CBRX, clinical trials, Columbia Laboratories, earnings, FDA, Food and Drug Administration, forecast, Linear Technology Corp., LLTC, NASDAQ, NASDAQ:CBRX, NASDAQ:LLTC, NASDAQ:UEPS, Net 1 UEPS Technologies, net income, predicted, quarter, report, revenue, SASSA, selloff, share, shars, stock, UEPS | Comments Off

Tuesday’s big time losers and the reasons why (CBRX, SAVE, KGC)

Posted on January 17, 2012 by Martin Timble

In this report: Kinross Gold (NYSE:KGC), Columbia Laboratories (NASDAQ:CBRX) and Sprint Airlines (NASDAQ:SAVE).

Columbia Laboratories (NASDAQ:CBRX) shares have sank by more than 56 percent so far today after reviewers from the Food and Drug Administration said that the company’s gel …

Posted in Latest Headlines, Reports | Tagged advisory panel, Africa, CBRX, clinical trials, Columbia Laboratories, common stock, Construction, costs, expenses, FDA, Food and Drug Administration, Gold, KGC, Kinross Gold, NASDAQ, NASDAQ:CBRX, NASDAQ:SAVE, NYSE, NYSE:KGC, operating, ounces, productions, risk, save, secondary offering, shareholders, shares, Sprint Airlines | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.